Literature DB >> 23222204

Use of probiotics in various diseases: evidence and promises.

Mine D Tanriover1, Duygu Y Aksoy, Serhat Unal.   

Abstract

The utilization of live microorganisms as therapeutics has been gaining increasing attention over the last years with the addition of scientific knowledge on their traditional uses. Probiotics are defined as "live micro‑organisms which when administered in adequate amounts, confer a health benefit on the host". The normal intestinal microbiota prevents the colonization of pathogenic bacteria and has important immune functions. It has been hypothesized that the sudden change in the intestinal microbiota that parallels the modern life practices of humans might have contributed to the rise in the incidence of particular diseases. Bacteria and yeasts may be used as probiotics either in the form of a single strain or combination of microorganisms or mixed with prebiotics. Probiotics have been used for various disease states from gastrointestinal diseases to infections and even to diabetes and atopic diseases. Drawing firm conclusions about the clinical efficacy of probiotics is hard because of the heterogeneity of patient populations, probiotic strains, dosages, and commercial preparations. However, probiotics represent a very exciting and promising area of research due to the ever-increasing antibiotic resistance rates and the ability of some probiotics to modify the course of diseases.

Entities:  

Mesh:

Year:  2012        PMID: 23222204

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  6 in total

1.  Potential for tyndalized Lactobacillus acidophilus as an effective component in moisturizing skin and anti-wrinkle products.

Authors:  A-Rang Im; Hui Seong Kim; Jin Won Hyun; Sungwook Chae
Journal:  Exp Ther Med       Date:  2016-05-31       Impact factor: 2.447

2.  Effects of Probiotic Supplementation on Pancreatic β-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial.

Authors:  Tanaz Shoaei; Motahar Heidari-Beni; Hatav Ghasemi Tehrani; Awat Feizi; Ahmad Esmaillzadeh; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2015-03-24

Review 3.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

4.  Probiotics in Adolescent Prediabetes: A Pilot RCT on Glycemic Control and Intestinal Bacteriome.

Authors:  Charikleia Stefanaki; Athanasios Michos; George Mastorakos; Aimilia Mantzou; Georgios Landis; Paraskevi Zosi; Flora Bacopoulou
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

5.  Importance of gut microbiota in health and diseases of new born infants.

Authors:  Jisheng Gao; Hongwei Wu; Jinfeng Liu
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

6.  The Effect of Oral Probiotic on the Interleukin-10 Serum Levels of Acne Vulgaris.

Authors:  Tissan Rahmayani; Imam Budi Putra; Nelva Karmilla Jusuf
Journal:  Open Access Maced J Med Sci       Date:  2019-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.